Fox Run Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,882
Closed -$83.7K 1121
2023
Q4
$83.7K Sell
12,882
-15,413
-54% -$99.3K 0.02% 686
2023
Q3
$267K Buy
+28,295
New +$341K 0.08% 480
2018
Q4
Sell
-11,321
Closed -$78K 781
2018
Q3
$78K Buy
+11,321
New +$67.1K 0.03% 534

Other funds holding CDMO

Fox Run Management's CDMO Position: Q1 2024 in Review

Fox Run Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 12,882 shares — an estimated $83.7K sold.

Fox Run Management first reported a position in CDMO in Q3 2018 and held it in 3 quarters. The position peaked at $267K in Q3 2023. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Fox Run Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fox Run Management sold 12,882 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $83.7K.
  • Fox Run Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • Fox Run Management's Avid Bioservices, Inc. Common Stock position peaked at $267K in Q3 2023.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Fox Run Management's 13F filing for Q1 2024, filed 13 May 2024.